(Q34468676)

2 August 2017

title

Is a decreased serum testosterone level a risk factor for prostate cancer? A cohort study of korean men. (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

1 reference

Eu Chang Hwang

2

0 references

Kwangsung Park

object named as

Kwangsung Park

8

0 references

Sun-Ouck Kim

4

object named as

Sun-Ouck Kim

1 reference

2 August 2017

6

Taek Won Kang

1 reference

2 August 2017

9

Soo Bang Ryu

1 reference

2 August 2017

Bo Sung Shin

1

1 reference

2 August 2017

Chang Min Im

3

1 reference

2 August 2017

Seung Il Jung

5

1 reference

2 August 2017

Dong Deuk Kwon

7

1 reference

2 August 2017

publication date

21 December 2010

1 reference

Korean Journal of Urology

2 August 2017

published in

1 reference

2 August 2017

volume

51

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

819-823

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

2 August 2017

copyright license

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screening

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Mechanisms of disease: Polymorphisms of androgen regulatory genes in the development of prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Role of estrogens in development of prostate cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Detection of prostate cancer and predicting progression: current and future diagnostic markers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Elevated expression of inhibin alpha in prostate cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Hormones and prostate cancer: current perspectives and future directions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Estrogen receptor beta in prostate cancer: brake pedal or accelerator?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

The role of steroid hormones in prostate carcinogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

6 July 2018

Hormonal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Occult prostate cancer in men with low serum testosterone levels

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Endogenous sex hormones and the risk of prostate cancer: a prospective study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Association between prostate cancer and serum testosterone levels

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

High-grade prostate cancer is associated with low serum testosterone levels

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Influence of radical prostatectomy on serum hormone levels

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3016426

Is low serum free testosterone a marker for high grade prostate cancer?

27 October 2018

1 reference

12 December 2020

Androgen, estrogen, and progesterone receptor contents and serum hormone profiles in patients with benign hypertrophy and carcinoma of the prostate

1 reference

12 December 2020

Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma

1 reference

12 December 2020

Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer

1 reference

12 December 2020

Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer

1 reference

12 December 2020

[The role of PSA in diagnosis of prostate cancer and its recurrence]

1 reference

12 December 2020

Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score

1 reference

12 December 2020

Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma

1 reference

12 December 2020

10.4111/KJU.2010.51.12.819

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference